ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 2588

$1.01M Total Retail Price of All Prescriptions

Rank: 85 out of 2588

419 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

30% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 551 281 S3 1 7
SIMVASTATIN 431 350 2 1
FUROSEMIDE 427 347 3 5
LISINOPRIL 415 319 4 3
LEVOTHYROXINE SODIUM 404 326 5 2
WARFARIN SODIUM 355 311 6 10
OMEPRAZOLE 342 247 7 6
POTASSIUM CHLORIDE 279 213 8 15
METOPROLOL SUCCINATE 277 232 9 12
AMLODIPINE BESYLATE 274 234 10 4
METFORMIN HCL 267 181 11 8
DONEPEZIL HCL 259 249 12 22
NAMENDA 258 248 13 32
CARVEDILOL 248 224 14 20
METOPROLOL TARTRATE 199 140 15 9
ATORVASTATIN CALCIUM 193 167 16 11
HYDROCHLOROTHIAZIDE 182 148 17 13
LANTUS 174 132 18 47
GABAPENTIN 166 99 19 18
NEXIUM 155 107 20 41
RANITIDINE HCL 153 91 21 37
DIOVAN 147 135 22 29
SPIRONOLACTONE 141 125 23 58
SERTRALINE HCL 137 102 24 26
ALLOPURINOL 133 114 25 33
FAMOTIDINE 131 97 26 36
CYMBALTA 125 73 27 70
TRICOR 121 64 28 122
ATENOLOL 120 87 29 14
TAMSULOSIN HCL 117 111 30 23
SPIRIVA 117 104 30 56
CRESTOR 117 96 30 25
PREDNISONE 114 84 33 42
PANTOPRAZOLE SODIUM 114 82 33 28
CLOPIDOGREL 112 96 35 30
ALBUTEROL SULFATE 109 69 36 116
CEFUROXIME 107 90 37 183
ESCITALOPRAM OXALATE 103 79 38 68
FENOFIBRATE 99 73 39 64
HYDRALAZINE HCL 99 86 39 53
OLANZAPINE 99 85 39 126
PLAVIX 95 81 42 43
ROPINIROLE HCL 95 71 42 113
PRAVASTATIN SODIUM 95 86 42 16
LEVOFLOXACIN 93 62 45 77
FENTANYL 93 60 S2 45 78
MIRTAZAPINE 92 72 47 63
DIVALPROEX SODIUM 91 31 48 89
LOSARTAN POTASSIUM 88 80 49 17
ZETIA 87 54 50 69
GLYBURIDE 85 80 R 51 65
ALENDRONATE SODIUM 85 84 51 21
POLYETHYLENE GLYCOL 3350 84 73 53 55
CITALOPRAM HBR 83 71 54 27
ZOLPIDEM TARTRATE 82 53 55 24
IPRATROPIUM-ALBUTEROL 82 73 55 104
SYMBICORT 80 48 57 129
NOVOLOG 79 55 58 103
KLOR-CON M10 76 68 59 139
SINGULAIR 74 30 60 94
LYRICA 74 51 60 100
HUMALOG 73 58 62 141
INSULIN SYRINGE 70 40 63 81
DIGOXIN 69 29 64 38
NABUMETONE 68 36 65 147
ADVAIR DISKUS 68 44 65 48
AMITIZA 68 50 65 302
IPRATROPIUM BROMIDE 66 39 68 159
JANTOVEN 65 65 69 267
KLOR-CON M20 63 44 70 52
DOXYCYCLINE HYCLATE 59 42 71 151
CYCLOBENZAPRINE HCL 59 30 R 71 87
OXYBUTYNIN CHLORIDE ER 59 52 71 85
TIZANIDINE HCL 57 24 74 225
TORSEMIDE 57 37 74 133
MUPIROCIN 55 25 76 235
VENLAFAXINE HCL ER 54 37 77 125
MEGESTROL ACETATE 53 48 R 78 169
QUETIAPINE FUMARATE 53 39 78 74
PHENYTOIN 53 22 78 280
TRAMADOL HCL 52 45 81 19
ISOSORBIDE MONONITRATE ER 52 52 81 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 35 83 35
TRAZODONE HCL 50 32 84 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.